Geron reported $-27976000 in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Amgen AMGN:US USD 2.66B 71M
Cti Biopharma CTIC:US USD -12218000 6.66M
Cytokinetics CYTK:US USD -108441000 97.57M
Esperion Therapeutics ESPR:US USD -41623000 10.75M
Exelixis EXEL:US USD 82.61M 1.09M
Genmab GEN:DC DKK 1.93B 684M
Gilead Sciences GILD:US USD 2.81B 784M
Macrogenics MGNX:US USD -24955000 16.85M
Novartis NOVN:VX USD 3.33B 8M
Pain Therapeutics PTIE:US USD -21345000 1.43M
Seattle Genetics SGEN:US USD -192805000 59.69M
YTE INCY:US USD 118.25M 142.04M